NewsMedium impact
Arcus Biosciences (RCUS) to Present Kidney Cancer Drug Data in Upcoming Virtual Meeting
gurufocus.com·5 hours ago·Unknown·1 min read
Rigense market context
News
No image available. Showing a neutral Rigense placeholder.
On October 18, 2026, Arcus Biosciences Inc (NYSE: RCUS) announced that management will present updated findings on casdatifan, a potential treatment for kidney
Related news
News
AbbVie (ABBV) to Showcase Expanded Solid Tumor Research at ESMO Congress
gurufocus.com
News
San Diego County Unemployment Declines to 4.7% in September - 10News.com
10News.com
News
ECONOMIC WEEK AHEAD: October 19 - 23 - Yardeni QuickTakes
Yardeni QuickTakes
News
China's Export Controls on Solar Tech May Challenge Tesla's Global Expansion (TSLA)
gurufocus.com
News
Elon Musk Unveils "Sentient" Tesla Roadster with Autonomous Stunt Capabilities (TSLA)
gurufocus.com
News
Andrew Left Appeals Securities Fraud Conviction Amid Insider Trading Probe; Impact on LOPE Investors
gurufocus.com